nach oben

Social Psychiatry and Psychiatric Epidemiology

Erschienen in:

01.05.2014 | Original Paper

Cancer mortality among psychiatric patients treated in a community-based system of care: a 25-year case register study

verfasst von: Giovanni Perini, Laura Grigoletti, Batul Hanife, Annibale Biggeri, Michele Tansella, Francesco Amaddeo

Erschienen in: Social Psychiatry and Psychiatric Epidemiology | Ausgabe 5/2014

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Cancer mortality data allow assessing, at the same time, the risk of developing the disease and the quality of care provided to patients after the oncologic diagnosis. This study explores the risk of death caused by a single tumor site in a psychiatric population treated in a community-based psychiatric service.

Methods

All patients with an ICD-10 psychiatric diagnosis, seeking care in 1982–2006 (25 years), were included. Data were drawn from the South Verona Psychiatric Case Register (PCR). Mortality and cause of death were ascertained using different procedures and sources. Standardized mortality ratios (SMRs) were used to compare the observed number of deaths with the expected number using as reference a population in the Veneto region.

Results

Having been admitted to the hospital (SMR = 1.32), having a short interval from registration (1.52), having a diagnosis of alcoholism (2.03), and being a middle-aged male (1.83) were factors showing an increased risk of death from cancer. Increased SMRs were found for cancer of the oral cavity (22.93), lymphoma, leukemias, Hodgkin's lymphoma (8.01), and central nervous system (CNS) and cranial nerve tumors (4.75). The SMR decreased for stomach tumors (0.49). Patients with alcoholism (5.90 for larynx), affective disorders (20.00 for lymphomas), and personality disorders (28.00 for SNC) were found to be exposed to a high risk of cancer death in specific sites.

Conclusions

Psychiatric patients showed different patterns of site-specific cancer mortality when compared with the general population. The 20-fold higher risk of dying from hematological neoplasms needs further investigation. Chronic use of phenothiazines could be involved in the relative protection from stomach and prostate cancer found in psychiatric patients.

Barak Y, Achiron A, Mandel M, Mirecki I, Aizenberg D (2005) Reduced cancer incidence among patients with schizophrenia. Cancer 104:2817–2821PubMedCrossRef

Barak Y, Levy T, Achiron A, Aizenberg D (2008) Breast cancer in women suffering from serious mental illness. Schizophr Res 102:249–253PubMedCrossRef

Gulbinat W, Dupont A, Jablensky A, Jensen OM, Marsella A, Nakane Y, Sartorius N (1992) Cancer incidence of schizophrenic patients. Results of record linkage studies in three countries. Br J Psychiatry Suppl (18):75–83

Park JK, Lee HJ, Kim JW, Park YH, Lee SS, Chang HI, Song JY, Yoon DJ, Bahn GH, Shin YH, Kim YJ, Kim SA, Choe BK, Kim CJ, Chung JH (2004) Differences in p53 gene polymorphisms between Korean schizophrenia and lung cancer patients. Schizophr Res 67:71–74PubMedCrossRef

Choi JH, Yang YR, Lee SK, Kim SH, Kim YH, Cha JY, Oh SW, Ha JR, Ryu SH, Suh PG (2008) Potential inhibition of PDK1/Akt signaling by phenothiazines suppresses cancer cell proliferation and survival. Ann N Y Acad Sci 1138:393–403PubMedCrossRef

Grinshpoon A, Barchana M, Ponizovsky A, Lipshitz I, Nahon D, Tal O, Weizman A, Levav I (2005) Cancer in schizophrenia: is the risk higher or lower? Schizophr Res 73:333–341PubMedCrossRef

Lichtermann D, Ekelund J, Pukkala E, Tanskanen A, Lonnqvist J (2001) Incidence of cancer among persons with schizophrenia and their relatives. Arch Gen Psychiatry 58:573–578PubMedCrossRef

Oksbjerg-Dalton S, Munk LT, Mellemkjaer L, Johansen C, Mortensen PB (2003) Schizophrenia and the risk for breast cancer. Schizophr Res 62:89–92PubMedCrossRef

Cohen M, Dembling B, Schorling J (2002) The association between schizophrenia and cancer: a population-based mortality study. Schizophr Res 57:139–146PubMedCrossRef

10.

Black DW, Winokur G (1986) Cancer mortality in psychiatric patients: the Iowa Record-linkage Study. Int J Psychiatry Med 16:189–197PubMedCrossRef

11.

Amaddeo F, Barbui C, Perini G, Biggeri A, Tansella M (2007) Avoidable mortality of psychiatric patients in an area with a community-based system of mental health care. Acta Psychiatr Scand 115:320–325PubMedCrossRef

12.

Chou FH, Tsai KY, Su CY, Lee CC (2011) The incidence and relative risk factors for developing cancer among patients with schizophrenia: a nine-year follow-up study. Schizophr Res 129:97–103PubMedCrossRef

13.

Guan NC, Termorshuizen F, Laan W, Smeets HM, Zainal NZ, Kahn RS, De Wit NJ, Boks MP (2012) Cancer mortality in patients with psychiatric diagnoses: a higher hazard of cancer death does not lead to a higher cumulative risk of dying from cancer. Soc Psychiatry Psychiatr Epidemiol

14.

Kisely S, Smith M, Lawrence D, Maaten S (2005) Mortality in individuals who have had psychiatric treatment: population-based study in Nova Scotia. Br J Psychiatry 187:552–558PubMedCrossRef

15.

Zaridze D, Brennan P, Boreham J, Boroda A, Karpov R, Lazarev A, Konobeevskaya I, Igitov V, Terechova T, Boffetta P, Peto R (2009) Alcohol and cause-specific mortality in Russia: a retrospective case-control study of 48,557 adult deaths. Lancet 373:2201–2214PubMedCentralPubMedCrossRef

16.

Goldacre MJ, Kurina LM, Wotton CJ, Yeates D, Seagroat V (2005) Schizophrenia and cancer: an epidemiological study. Br J Psychiatry 187:334–338PubMedCrossRef

17.

Kisely S, Sadek J, MacKenzie A, Lawrence D, Campbell LA (2008) Excess cancer mortality in psychiatric patients. Can J Psychiatry 53:753–761PubMed

18.

Saku M, Tokudome S, Ikeda M, Kono S, Makimoto K, Uchimura H, Mukai A, Yoshimura T (1995) Mortality in psychiatric patients, with a specific focus on cancer mortality associated with schizophrenia. Int J Epidemiol 24:366–372PubMedCrossRef

19.

Amaddeo F, Burti L, Ruggeri M, Tansella M (2009) Long-term monitoring and evaluation of a new system of community-based psychiatric care. Integrating research, teaching and practice at the University of Verona. Ann Ist Super Sanita 45:43–53PubMed

20.

Breslow NE, Day NE (1987) Statistical methods in cancer research: the design and analysis of cohort studies, vol 2. International Agency for Research on Cancer, Lyon

21.

Lebovits AH, Strain JJ, Schleifer SJ, Tanaka JS, Bhardwaj S, Messe MR (1990) Patient noncompliance with self-administered chemotherapy. Cancer 65:17–22PubMedCrossRef

22.

Cerullo MA (2008) Expect psychiatric side effects from corticosteroid use in the elderly. Geriatrics 63:15–18PubMed

23.

Miller AH, Ancoli-Israel S, Bower JE, Capuron L, Irwin MR (2008) Neuroendocrine-immune mechanisms of behavioral comorbidities in patients with cancer. J Clin Oncol 26:971–982PubMedCentralPubMedCrossRef

24.

Lawrence D, Holman CD, Jablensky AV, Threlfall TJ, Fuller SA (2000) Excess cancer mortality in Western Australian psychiatric patients due to higher case fatality rates. Acta Psychiatr Scand 101:382–388PubMedCrossRef

25.

Druss BG, Bradford DW, Rosenheck RA, Radford MJ, Krumholz HM (2000) Mental disorders and use of cardiovascular procedures after myocardial infarction. JAMA 283:506–511PubMedCrossRef

26.

O’Rourke RW, Diggs BS, Spight DH, Robinson J, Elder KA, Andrus J, Thomas CR, Hunter JG, Jobe BA (2008) Psychiatric illness delays diagnosis of esophageal cancer. Dis Esophagus 21:416–421PubMedCentralPubMedCrossRef

27.

Lasalvia A, Tansella M (2008) Fighting discrimination and stigma against people with mental disorders. Epidemiol Psichiatr Soc 17:1–9PubMed

28.

Thornicroft G (2008) Stigma and discrimination limit access to mental health care. Epidemiol Psichiatr Soc 17:14–19PubMedCrossRef

29.

Tiihonen J, Lonnqvist J, Wahlbeck K, Klaukka T, Niskanen L, Tanskanen A, Haukka J (2009) 11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study). Lancet

30.

Tran E, Rouillon F, Loze JY, Casadebaig F, Philippe A, Vitry F, Limosin F (2009) Cancer mortality in patients with schizophrenia: an 11-year prospective cohort study. Cancer 115:3555–3562PubMedCrossRef

31.

Mortensen PB (1992) Neuroleptic medication and reduced risk of prostate cancer in schizophrenic patients. Acta Psychiatr Scand 85:390–393PubMedCrossRef

32.

Kurihara T, Nojima K, Sakagami H, Motohashi N, Molnar J (1999) Electronic structure and cytotoxic activity of “half-mustard type” phenothiazines by MM3 and PM3 methods. Anticancer Res 19:3895–3899PubMed

33.

Dalack GW, Healy DJ, Meador-Woodruff JH (1998) Nicotine dependence in schizophrenia: clinical phenomena and laboratory findings. Am J Psychiatry 155:1490–1501PubMed

34.

Bushe CJ, Hodgson R (2010) Schizophrenia and cancer: in 2010 do we understand the connection? Can J Psychiatry 55(12):761–767PubMed

35.

Gask L, Coventry P (2012) Person-centred mental health care: the challenge of implementation. Epidemiol Psychiatr Sci 21:139–144PubMedCrossRef

36.

Salvador-Carulla L, Mezzich JE (2012) Person-centred medicine and mental health. Epidemiol Psychiatr Sci 21:131–137PubMedCrossRef

Titel: Cancer mortality among psychiatric patients treated in a community-based system of care: a 25-year case register study
verfasst von: Giovanni Perini
Laura Grigoletti
Batul Hanife
Annibale Biggeri
Michele Tansella
Francesco Amaddeo
Publikationsdatum: 01.05.2014
Verlag: Springer Berlin Heidelberg
Erschienen in: Social Psychiatry and Psychiatric Epidemiology / Ausgabe 5/2014
Print ISSN: 0933-7954
Elektronische ISSN: 1433-9285
DOI: https://doi.org/10.1007/s00127-013-0765-0

Neu im Fachgebiet Psychiatrie

ADHS-Medikation erhöht das kardiovaskuläre Risiko

16.05.2024 Herzinsuffizienz Nachrichten

Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.

Typ-2-Diabetes und Depression folgen oft aufeinander

14.05.2024 Typ-2-Diabetes Nachrichten

Menschen mit Typ-2-Diabetes sind überdurchschnittlich gefährdet, in den nächsten Jahren auch noch eine Depression zu entwickeln – und umgekehrt. Besonders ausgeprägt ist die Wechselbeziehung laut GKV-Daten bei jüngeren Erwachsenen.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Spezielles Sportprogramm bei einer Reihe von psychischen Erkrankungen effektiv

08.05.2024 Psychotherapie Nachrichten

Sportliche Betätigung hilft nicht nur bei Depression, sondern auch in Gruppen von Patientinnen und Patienten mit unterschiedlichen psychischen Erkrankungen, wie Insomnie, Panikattacken, Agoraphobie und posttraumatischem Belastungssyndrom. Sie alle profitieren längerfristig.

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Cancer mortality among psychiatric patients treated in a community-based system of care: a 25-year case register study